XML 41 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule I (Notes)
 12 Months Ended
Dec. 31, 2020
Condensed Statement of Income Captions [Line Items]  
Condensed Financial Information of Parent Company Only Disclosure [Text Block]
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Balance Sheets
 
(in millions, except per share data)December 31,
2020		December 31,
2019
Assets  
Current assets:  
Cash and cash equivalents$258 $46 
Other current assets562 787 
Total current assets820 833 
Equity in net assets of subsidiaries107,714 93,467 
Long-term notes receivable from subsidiaries5,021 5,079 
Other assets342 794 
Total assets$113,897 $100,173 
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities
$589 $688 
Current portion of notes payable to subsidiaries
4,882 750 
Short-term borrowings and current maturities of long-term debt4,465 3,548 
Total current liabilities9,936 4,986 
Long-term debt, less current maturities37,815 35,926 
Long-term notes payable to subsidiaries— 1,314 
Other liabilities655 331 
Total liabilities48,406 42,557 
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding
— — 
Common stock, $0.01 par value - 3,000 shares authorized; 946 and 948 issued and outstanding
10 9 
Additional paid-in capital— 7 
Retained earnings69,295 61,178 
Accumulated other comprehensive loss(3,814)(3,578)
Total UnitedHealth Group shareholders’ equity65,491 57,616 
Total liabilities and shareholders’ equity$113,897 $100,173 
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Comprehensive Income
 
 For the Years Ended December 31,
(in millions)202020192018
Revenues: 
Investment and other income$194 $209 $194 
Total revenues194 209 194 
Operating costs:
Operating costs
27 38 35 
Interest expense
1,594 1,580 1,285 
Total operating costs1,621 1,618 1,320 
Loss before income taxes(1,427)(1,409)(1,126)
Benefit for income taxes300 293 251 
Loss of parent company(1,127)(1,116)(875)
Equity in undistributed income of subsidiaries16,530 14,955 12,861 
Net earnings15,403 13,839 11,986 
Other comprehensive (loss) income (236)582 (1,517)
Comprehensive income$15,167 $14,421 $10,469 
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Cash Flows
 
 For the Years Ended December 31,
(in millions)202020192018
Operating activities 
Cash flows from operating activities$8,842 $9,275 $6,099 
Investing activities
Issuances of notes to subsidiaries(628)(2,722)(1,420)
Repayments of notes to subsidiaries1,089 2,249 1,419 
Cash paid for acquisitions(7,706)(9,645)(4,066)
Return of capital to parent company943 4,497 4,196 
Capital contributions to subsidiaries(43)(803)(1,259)
Other, net143 490 4 
Cash flows used for investing activities(6,202)(5,934)(1,126)
Financing activities
Common stock repurchases(4,250)(5,500)(4,500)
Proceeds from common stock issuances1,440 1,037 838 
Cash dividends paid(4,584)(3,932)(3,320)
Proceeds from (repayments of) short-term borrowings, net872 300 (201)
Proceeds from issuance of long-term debt4,864 5,444 6,935 
Repayments of long-term debt(3,150)(1,750)(2,600)
Proceeds (repayments) of notes from subsidiaries2,818 1,207 (1,127)
Other, net(438)(535)(923)
Cash flows used for financing activities(2,428)(3,729)(4,898)
Increase (decrease) in cash and cash equivalents212 (388)75 
Cash and cash equivalents, beginning of period46 434 359 
Cash and cash equivalents, end of period$258 $46 $434 
Supplemental cash flow disclosures
Cash paid for interest$1,633 $1,506 $1,294 
Cash paid for income taxes4,185 2,590 2,379 
See Notes to the Condensed Financial Statements of Registrant
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Notes to Condensed Financial Statements
1.    Basis of Presentation
UnitedHealth Group’s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form 10-K. The accounting policies for the registrant are the same as those described in Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements.”
2.    Subsidiary Transactions
Investment in Subsidiaries. UnitedHealth Group’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.
Dividends and Capital Distributions. Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $10.0 billion, $5.6 billion and $5.6 billion in 2020, 2019 and 2018, respectively. Additionally, $0.9 billion, $4.5 billion and $4.2 billion in cash were received as a return of capital to the parent company during 2020, 2019 and 2018, respectively.
3.    Short-Term Borrowings and Long-Term Debt
Discussion of short-term borrowings and long-term debt can be found in Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements.” Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $1.2 billion at December 31, 2020 and 2019.
Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions)
2021$4,446 
20223,015 
20232,125 
20241,500 
20252,300 
Thereafter29,177 
UnitedHealth Group’s parent company had notes payable to subsidiaries of $4.9 billion as of December 31, 2020, which included on-demand features.
4. Commitments and Contingencies
Certain regulated subsidiaries are guaranteed by UnitedHealth Group’s parent company in the event of insolvency. UnitedHealth Group’s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December 31, 2020, 2019 or 2018.